Clinical aspects and laboratory problems in hereditary thrombophilia

Area of Science:

• Genetics
• Hematology
• Molecular Biology

Background:

• Hereditary thrombophilia is a complex, multifactorial disorder with diverse clinical manifestations.
• Common genetic factors include Factor V (FV) Leiden and FII gene mutations, alongside deficiencies in antithrombin, protein C, and protein S.
• The clinical expression and risk of venous thrombosis vary significantly among different thrombophilias.

Purpose of the Study:

• To explore the heterogeneity in clinical expression of hereditary thrombophilia.
• To compare the risks associated with Factor V Leiden and FII gene mutations.
• To discuss the diagnostic strategies and potential unidentified genetic factors.

Main Methods:

• Review of existing literature on hereditary thrombophilia.
• Analysis of clinical data regarding venous thrombosis risk and recurrence.
• Examination of geographic and ethnic distributions of genetic mutations.

Main Results:

• Heterozygous carriers of FV Leiden or FII mutations have a lower risk of venous thrombosis compared to other thrombophilias.
• FV Leiden mutation carriers tend to have a later age of first thrombotic episode, while FII mutation carriers show higher recurrence rates.
• Co-inheritance of mutations significantly elevates thrombosis risk, with specific mutations linked to arterial thrombosis and fetal loss.

Conclusions:

• Hereditary thrombophilia exhibits significant heterogeneity in clinical presentation and risk, influenced by specific gene mutations and their combinations.
• The geographic and ethnic distribution of mutations suggests a founder effect.
• Accurate laboratory diagnosis requires careful patient selection and consideration of preanalytical variables, with potential for undiscovered genetic contributors.